The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation
Open accessAbstract
Obesity favors the development of cardiometabolic alterations such as type 2 diabetes (T2D) and the metabolic syndrome (MS). Obesity and the MS are distinguished by an increase in circulating leptin concentrations, in parallel to a drop in the levels of adiponectin. Consequently, the Adpn/Lep ratio has been suggested as a maker of dysfunctional adipose tissue. We aimed to investigate in humans (n = 292) the reliability of the Adpn/Lep ratio as a biomarker of adipose tissue dysfunction. We considered that an Adpn/Lep ratio of ≥1.0 can be considered normal, a ratio of ≥0.5 <1.0 suggests moderate-medium increased risk, and a ratio of <0.5 indicates a severe increase in cardiometabolic risk. Using these cut-offs, 5%, 54% and 48% of the lean, normoglycemic and without-MS subjects, respectively, fall within the group with an Adpn/Lep ratio below 0.5; while 89%, 86% and 90% of the obese, with T2D and with MS patients fall within the same group (p < 0.001). A significant negative correlation (r = −0.21, p = 0.005) between the Adpn/Lep ratio and serum amyloid A (SAA) concentrations, a marker of adipose tissue dysfunction, was found. We concluded that the Adpn/Lep ratio is a good indicator of a dysfunctional adipose tissue that may be a useful estimator of obesity- and MS-associated cardiometabolic risk, allowing the identification of a higher number of subjects at risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Classification and Diagnosis of Diabetes
Fajans, S. S. (1990) · Medical Entomology and Zoology · Cited by 2,359
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Blundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Self-citationAmato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1825 · Cited by 1,751
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
Bray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00271-3 · Cited by 1,036
Self-citationStern, J. H., Rutkowski, J. M., & Scherer, P. E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.011 · Cited by 1,031
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
Crewe, C., An, Y. A., & Scherer, P. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88883 · Cited by 732
Gómez-Ambrosi, J., Silva, C., Galofré, J. C., Escalada, J., Santos, S., Millán, D., Vila, N., Ibañez, P., Gil, M. J., Valentí, V, et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.100 · Cited by 615
Self-citationAdipokine dysregulation and adipose tissue inflammation in human obesity
Unamuno, X., Gómez‐Ambrosi, J., Rodríguez, A., Becerril, S., Frühbeck, G., & Catalán, V. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12997 · Cited by 610
Self-citationFrühbeck, G., Catalán, V., Rodríguez, A., & Gómez-Ambrosi, J. (2018) · Adipocyte · doi:10.1080/21623945.2017.1402151 · Cited by 430
Self-citationBlüher, M., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.016 · Cited by 399
Yang, R.-Z., Lee, M.-J., Hu, H., Pollin, T. I., Ryan, A. S., Nicklas, B. J., Snitker, S., Horenstein, R. B., Hull, K., Goldberg, N. H., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030287 · Cited by 355
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
Amato, M. C., & Giordano, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/730827 · Cited by 350
Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 282
Self-citationClinical Usefulness of a New Equation for Estimating Body Fat
Gómez-Ambrosi, J., Silva, C., Catalán, V., Rodríguez, A., Galofré, J. C., Escalada, J., Valentí, V., Rotellar, F., Romero, S., Ramírez, B., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1334 · Cited by 275
Self-citationFrühbeck, G., Toplak, H., Woodward, E., Yumuk, V., Maislos, M., Oppert, J.-M., & for the Executive Committee of the European Association for the Study of Obesity (2013) · Obesity Facts · doi:10.1159/000350627 · Cited by 264
Self-citationPlasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity
Gómez-Ambrosi, J., Catalán, V., Ramírez, B., Rodríguez, A., Colina, I., Silva, C., Rotellar, F., Mugueta, C., Gil, M. J., Cienfuegos, J. A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0349 · Cited by 211
Self-citationFrühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Salvador, J., Portincasa, P., Colina, I., & Gómez-Ambrosi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-06997-0 · Cited by 211
Self-citationDifferential Role of Leptin and Adiponectin in Cardiovascular System
Ghantous, C. M., Azrak, Z., Hanache, S., Abou-Kheir, W., & Zeidan, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/534320 · Cited by 204
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez‐Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 167
Self-citationAdipose tissue immunity and cancer
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., & Frühbeck, G. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00275 · Cited by 146
Self-citationGómez‐Ambrosi, J., Catalán, V., Rodríguez, A., Andrada, P., Ramírez, B., Ibáñez, P., Vila, N., Romero, S., Margall, M. A., Gil, M. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0937 · Cited by 135
Self-citationMetabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio
Vega, G. L., & Grundy, S. M. (2013) · Journal of Obesity · doi:10.1155/2013/409679 · Cited by 132
Hebebrand, J., Holm, J., Woodward, E., Baker, J. L., Blaak, E. E., Durrer-Schutz, D., Farpour‐Lambert, N. J., Frühbeck, G., Halford, J. C. G., Lissner, L., et al. (2017) · Obesity Facts · doi:10.1159/000479208 · Cited by 127
Self-citationControl of body weight: a physiologic and transgenic perspective
Frühbeck, G., & Gómez‐Ambrosi, J. (2003) · Diabetologia · doi:10.1007/s00125-003-1053-4 · Cited by 125
Self-citationGómez‐Ambrosi, J., Salvador, J., Páramo, J. A., Orbe, J., de Irala, J., Diez-Caballero, A., Gil, M. J., Cienfuegos, J. A., & Frühbeck, G. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00320-x · Cited by 125
Self-citationRationale for the existence of additional adipostatic hormones
Frühbeck, G., & Gómez‐Ambrosi, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0829hyp · Cited by 122
Self-citationIncreased Serum Amyloid A Concentrations in Morbid Obesity Decrease after Gastric Bypass
Gómez-Ambrosi, J., Salvador, J., Rotellar, F., Silva, C., Catalán, V., Rodríguez, A., Jesús Gil, M., & Frühbeck, G. (2006) · Obesity Surgery · doi:10.1381/096089206776116525 · Cited by 119
Self-citationTargeting the adiponectin leptin ratio for postmenopausal breast cancer prevention
Cleary, M. P., Ray, A., Rogozina, O. P., Dogan, S., & Grossmann, M. E. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s30 · Cited by 91
Peripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 74
Self-citationFrühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Portincasa, P., & Gómez‐Ambrosi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-02848-0 · Cited by 73
Self-citationIncreased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin
Gómez‐Ambrosi, J., Salvador, J., Silva, C., Pastor, C., Rotellar, F., Gil, M., Cienfuegos, J. A., & Frühbeck, G. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-02-0079 · Cited by 56
Self-citationGómez‐Ambrosi, J., Corrales, E. P., Catalán, V., Rodríguez, A., Ramírez, B., Romero, S., Vila, N., Ibáñez, P., Margall, M. A., Silva, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2084 · Cited by 45
Self-citationSerum Amyloid A Concentration is Increased in Obese Children and Adolescents
Gómez‐Ambrosi, J., Azcona, C., Patiño‐García, A., & Frühbeck, G. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.01.006 · Cited by 26
Self-citation
Cited by
Decreased adiponectin/leptin ratio relates to insulin resistance in adults with obesity
Castela, I., Morais, J., Barreiros-Mota, I., Silvestre, M. P., Marques, C., Rodrigues, C., Ismael, S., Araújo, J. R., Ângelo-Dias, M., Martins, C., et al. (2023) · American Journal of Physiology - Endocrinology and Metabolism · doi:10.1152/ajpendo.00273.2022 · Cited by 60
Danpanichkul, P., Suparan, K., Kim, D., & Wijarnpreecha, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13010278 · Cited by 54
“On one hand, anti-inflammatory adiponectin and inflammatory-inducing leptin, both of which can also be considered in terms of the adiponectin-to-leptin ratio, were examined to determine the status of adipose tissue inflammation or lipotoxicity [66–68].”
BackgroundMorais, J., Veiga, D., Ferreira, A. F., Alves, I., Castela, I., Ramalho, C., Miranda, J. O., Leite-Moreira, A., & Falcão-Pires, I. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00259.2025 · Cited by 7
Metadata
- Authors
- Frühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Salvador, J., Colina, I., & Gómez-Ambrosi, J.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-02-22
- Volume
- 11
- Issue
- 2
- Pages
- 454
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2916386271
- Cited by
- 262
- References
- 39
- FWCI
- 15.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.